T1	AdverseReaction 90 103	Eye disorders
T2	AdverseReaction 122 130	eye pain
T3	AdverseReaction 132 155	chemical conjunctivitis
T4	AdverseReaction 157 169	corneal burn
T5	AdverseReaction 171 183	eyelid edema
T6	AdverseReaction 185 198	eyelid ptosis
T7	AdverseReaction 200 217	periorbital edema
T8	AdverseReaction 419 439	Local skin reactions
T9	Factor 440 443	can
T10	Factor 218 221	can
T11	AdverseReaction 419 429;484 496	Local skin vesiculation
T12	AdverseReaction 419 429;497 508	Local skin pustulation
T13	AdverseReaction 419 429;510 517	Local skin erosion
T14	AdverseReaction 419 429;518 528	Local skin ulceration
T15	Severity 460 466	severe
T16	AdverseReaction 751 764	Eye disorders
T17	AdverseReaction 783 791	eye pain
T18	Severity 776 782	severe
T19	Severity 115 121	severe
T20	AdverseReaction 793 816	chemical conjunctivitis
T21	AdverseReaction 818 830	corneal burn
T22	AdverseReaction 832 844	eyelid edema
T23	AdverseReaction 846 859	eyelid ptosis
T24	AdverseReaction 861 878	periorbital edema
T25	AdverseReaction 1294 1320	Hypersensitivity reactions
T26	AdverseReaction 1332 1343	anaphylaxis
T27	AdverseReaction 1348 1375	allergic contact dermatitis
T28	AdverseReaction 1654 1688	skin reactions in the treated area
T29	Severity 1647 1653	Severe
T30	AdverseReaction 1654 1688;1700 1708	skin reactions in the treated area erythema
T31	AdverseReaction 1654 1688;1710 1718	skin reactions in the treated area crusting
T32	AdverseReaction 1654 1688;1720 1728	skin reactions in the treated area swelling
T33	AdverseReaction 1654 1688;1730 1742	skin reactions in the treated area vesiculation
T34	Factor 879 882	can
T35	AdverseReaction 1654 1688;1743 1754	skin reactions in the treated area postulation
T36	AdverseReaction 1654 1688;1760 1767	skin reactions in the treated area erosion
T37	AdverseReaction 1654 1688;1768 1778	skin reactions in the treated area ulceration
T38	Factor 1780 1783	can
E1	AdverseReaction:T1 Hypothetical:E10
E2	AdverseReaction:T2 Hypothetical:E10 Effect:E19
E3	AdverseReaction:T3 Hypothetical:E10
E4	AdverseReaction:T4 Hypothetical:E10
E5	AdverseReaction:T5 Hypothetical:E10
E6	AdverseReaction:T6 Hypothetical:E10
E7	AdverseReaction:T7 Hypothetical:E10
E8	AdverseReaction:T8 Hypothetical:E9
E9	Factor:T9
E10	Factor:T10
E11	AdverseReaction:T11 Effect:E15 Hypothetical:E9
E12	AdverseReaction:T12 Effect:E15 Hypothetical:E9
E13	AdverseReaction:T13 Effect:E15 Hypothetical:E9
E14	AdverseReaction:T14 Effect:E15 Hypothetical:E9
E15	Severity:T15
E16	AdverseReaction:T16 Hypothetical:E34
E17	AdverseReaction:T17 Effect:E18 Hypothetical:E34
E18	Severity:T18
E19	Severity:T19
E20	AdverseReaction:T20 Hypothetical:E34
E21	AdverseReaction:T21 Hypothetical:E34
E22	AdverseReaction:T22 Hypothetical:E34
E23	AdverseReaction:T23 Hypothetical:E34
E24	AdverseReaction:T24 Hypothetical:E34
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28 Effect:E29 Hypothetical:E38
E29	Severity:T29
E30	AdverseReaction:T30 Hypothetical:E38
E31	AdverseReaction:T31 Hypothetical:E38
E32	AdverseReaction:T32 Hypothetical:E38
E33	AdverseReaction:T33 Hypothetical:E38
E34	Factor:T34
E35	AdverseReaction:T35 Hypothetical:E38
E36	AdverseReaction:T36 Hypothetical:E38
E37	AdverseReaction:T37 Hypothetical:E38
E38	Factor:T38
A1	CUI E1 C0015397
A2	UMLS-Preferred-Name E1 Disorder of eye
A3	MEDDRA-PT E1 Eye disorder
A4	MEDDRA-PT-ID E1 10015916
A5	CUI E2 C0151827
A6	UMLS-Preferred-Name E2 Eye pain
A7	MEDDRA-PT E2 Eye pain
A8	MEDDRA-PT-ID E2 10015958
A9	CUI E3 C0149866
A10	UMLS-Preferred-Name E3 Chemical conjunctivitis
A11	MEDDRA-PT E3 Chemical eye injury
A12	MEDDRA-PT-ID E3 10055116
A13	LLT E3 Chemical conjunctivitis
A14	LLT-ID E3 10055119
A15	CUI E4 C0239116
A16	UMLS-Preferred-Name E4 Corneal burn
A17	MEDDRA-PT E4 Eye burns
A18	MEDDRA-PT-ID E4 10015911
A19	LLT E4 Corneal burn
A20	LLT-ID E4 10068161
A21	CUI E5 C0162285
A22	UMLS-Preferred-Name E5 Edema of eyelid
A23	MEDDRA-PT E5 Eyelid oedema
A24	MEDDRA-PT-ID E5 10015993
A25	LLT E5 Eyelid edema
A26	LLT-ID E5 10015985
A27	CUI E6 C0005745
A28	UMLS-Preferred-Name E6 Blepharoptosis
A29	MEDDRA-PT E6 Eyelid ptosis
A30	MEDDRA-PT-ID E6 10015995
A31	CUI E7 C0151205
A32	UMLS-Preferred-Name E7 Periorbital edema
A33	MEDDRA-PT E7 Periorbital oedema
A34	MEDDRA-PT-ID E7 10034545
A35	LLT E7 Periorbital edema
A36	LLT-ID E7 10054541
A37	CUI E8 C0549452
A38	UMLS-Preferred-Name E8 Localised skin reaction
A39	MEDDRA-PT E8 Skin reaction
A40	MEDDRA-PT-ID E8 10040914
A41	LLT E8 Localised skin reaction
A42	LLT-ID E8 10024777
A43	flag E11 duplicate
A44	CUI E11 C0858702
A45	UMLS-Preferred-Name E11 Drug eruption vesicular
A46	MEDDRA-PT E11 Drug eruption
A47	MEDDRA-PT-ID E11 10013687
A48	LLT E11 Drug eruption vesicular
A49	LLT-ID E11 10013694
A50	flag E12 duplicate
A51	CUI E12 C0549452
A52	UMLS-Preferred-Name E12 Localised skin reaction
A53	MEDDRA-PT E12 Skin reaction
A54	MEDDRA-PT-ID E12 10040914
A55	LLT E12 Localised skin reaction
A56	LLT-ID E12 10024777
A57	CUI E13 C3887524
A58	UMLS-Preferred-Name E13 Skin Erosion
A59	MEDDRA-PT E13 Skin erosion
A60	MEDDRA-PT-ID E13 10040840
A61	CUI E14 C0037299
A62	UMLS-Preferred-Name E14 Skin Ulcer
A63	MEDDRA-PT E14 Skin ulcer
A64	MEDDRA-PT-ID E14 10040943
A65	CUI E16 C0015397
A66	UMLS-Preferred-Name E16 Disorder of eye
A67	MEDDRA-PT E16 Eye disorder
A68	MEDDRA-PT-ID E16 10015916
A69	CUI E17 C0151827
A70	UMLS-Preferred-Name E17 Eye pain
A71	MEDDRA-PT E17 Eye pain
A72	MEDDRA-PT-ID E17 10015958
A73	CUI E20 C0149866
A74	UMLS-Preferred-Name E20 Chemical conjunctivitis
A75	MEDDRA-PT E20 Chemical eye injury
A76	MEDDRA-PT-ID E20 10055116
A77	LLT E20 Chemical conjunctivitis
A78	LLT-ID E20 10055119
A79	CUI E21 C0239116
A80	UMLS-Preferred-Name E21 Corneal burn
A81	MEDDRA-PT E21 Eye burns
A82	MEDDRA-PT-ID E21 10015911
A83	LLT E21 Corneal burn
A84	LLT-ID E21 10068161
A85	CUI E22 C0162285
A86	UMLS-Preferred-Name E22 Edema of eyelid
A87	MEDDRA-PT E22 Eyelid oedema
A88	MEDDRA-PT-ID E22 10015993
A89	LLT E22 Eyelid edema
A90	LLT-ID E22 10015985
A91	CUI E23 C0005745
A92	UMLS-Preferred-Name E23 Blepharoptosis
A93	MEDDRA-PT E23 Eyelid ptosis
A94	MEDDRA-PT-ID E23 10015995
A95	CUI E24 C0151205
A96	UMLS-Preferred-Name E24 Periorbital edema
A97	MEDDRA-PT E24 Periorbital oedema
A98	MEDDRA-PT-ID E24 10034545
A99	LLT E24 Periorbital edema
A100	LLT-ID E24 10054541
A101	CUI E25 C0020517
A102	UMLS-Preferred-Name E25 Hypersensitivity
A103	MEDDRA-PT E25 Hypersensitivity
A104	MEDDRA-PT-ID E25 10020751
A105	LLT E25 Hypersensitivity reaction
A106	LLT-ID E25 10020756
A107	CUI E26 C0002792
A108	UMLS-Preferred-Name E26 anaphylaxis
A109	MEDDRA-PT E26 Anaphylactic reaction
A110	MEDDRA-PT-ID E26 10002198
A111	LLT E26 Anaphylaxis
A112	LLT-ID E26 10002218
A113	CUI E27 C0162820
A114	UMLS-Preferred-Name E27 Dermatitis, Allergic Contact
A115	MEDDRA-PT E27 Dermatitis contact
A116	MEDDRA-PT-ID E27 10012442
A117	LLT E27 Allergic contact dermatitis
A118	LLT-ID E27 10056265
A119	CUI E28 C0549452
A120	UMLS-Preferred-Name E28 Localised skin reaction
A121	MEDDRA-PT E28 Skin reaction
A122	MEDDRA-PT-ID E28 10040914
A123	LLT E28 Localised skin reaction
A124	LLT-ID E28 10024777
A125	CUI E30 C0853700
A126	UMLS-Preferred-Name E30 Application site erythema
A127	MEDDRA-PT E30 Application site erythema
A128	MEDDRA-PT-ID E30 10003041
A129	CUI E31 C0948300
A130	UMLS-Preferred-Name E31 Application site scab
A131	MEDDRA-PT E31 Application site scab
A132	MEDDRA-PT-ID E31 10066209
A133	CUI E32 C1096001
A134	UMLS-Preferred-Name E32 Application site swelling
A135	MEDDRA-PT E32 Application site swelling
A136	MEDDRA-PT-ID E32 10053424
A137	CUI E33 C0877097
A138	UMLS-Preferred-Name E33 Application site vesicles
A139	MEDDRA-PT E33 Application site vesicles
A140	MEDDRA-PT-ID E33 10048941
A141	CUI E35 C0877128
A142	UMLS-Preferred-Name E35 Application site pustules
A143	MEDDRA-PT E35 Application site pustules
A144	MEDDRA-PT-ID E35 10049044
A145	CUI E36 C1696574
A146	UMLS-Preferred-Name E36 Application site erosion
A147	MEDDRA-PT E36 Application site erosion
A148	MEDDRA-PT-ID E36 10065577
A149	CUI E37 C0521492
A150	UMLS-Preferred-Name E37 Application site ulcer
A151	MEDDRA-PT E37 Application site ulcer
A152	MEDDRA-PT-ID E37 10003059
